GENEVA, Oct. 1 -- NMD PHARMA A/S filed a patent application (EP2026/056603) for “A CHLORIDE ION CHANNEL 1 INHIBITOR FOR USE IN DISEASE MODIFYING EFFECTS IN THE TREATMENT OF A NEUROMUSCULAR DISEASE”. With publication no. WO/2026/190100, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/192
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....